uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease
Show others and affiliations
2003 (English)In: Brain Research. Molecular Brain Research, ISSN 0169-328X, Vol. 116, no 1-2, 155-158 p.Article in journal (Refereed) Published
Abstract [en]

Beta-secretase (BACE) and glycogen synthase kinase (GSK 3) are two enzymes thought to play a role in Alzheimer's disease. We extracted mRNA from 90 Alzheimer and 81 control brains. Levels of mRNA were quantified for BACE and GSK 3 with TaqMan real-time RT-PCR. We found no change in the Alzheimer's disease brains relative to controls for either the BACE or the GSK 3alpha mRNA levels.

Place, publisher, year, edition, pages
2003. Vol. 116, no 1-2, 155-158 p.
Keyword [en]
Alzheimer Disease/*enzymology/genetics/metabolism, Amyloid beta-Protein Precursor/analysis/genetics, Comparative Study, Endopeptidases/genetics/*metabolism, Female, Glial Fibrillary Acidic Protein/analysis/genetics, Glycogen Synthase Kinase 3/genetics/*metabolism, Humans, Male, Microtubule-Associated Proteins/analysis/genetics, Phosphopyruvate Hydratase/analysis/genetics, RNA; Messenger/analysis/biosynthesis, Reverse Transcriptase Polymerase Chain Reaction/methods, Sex Characteristics
National Category
Neurosciences Genetics
URN: urn:nbn:se:uu:diva-72470PubMedID: 12941471OAI: oai:DiVA.org:uu-72470DiVA: diva2:100381
Available from: 2005-05-24 Created: 2005-05-24Bibliographically approved

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Jazin, Elena
By organisation
Evolutionary Biology
In the same journal
Brain Research. Molecular Brain Research

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 158 hits
ReferencesLink to record
Permanent link

Direct link